The standardized mortality rate for pancreas malignant neoplasms in Canada remains constant at 14.9 male deaths per hundred thousand men from 2024 to 2028. This plateau indicates no year-on-year variation during this period. As of 2023, the value stood at 14.9, suggesting a stabilization or lack of identified shifts in previous years leading up to 2024. No significant trends or calculated CAGR is measurable given the homogeneous data predictions for these years.

Future trends to watch for:

Developments in medical technology and treatment options which could impact mortality rates.
Changes in public health policy and awareness campaigns focusing on risk factors and early detection.
Demographic changes influencing incidence and mortality rates among different age groups.